Analgesic therapy in postherpetic neuralgia: A quantitative systematic review

PLoS Medicine

Volumn 2, Issue 7, 2005, Pages 0628-0644

  Hempenstall, Kathleen ^a   Nurmikko, Turo J ^b   Johnson, Robert W ^c   A'Hern, Roger P ^d   Rice, Andrew S C ^e  

^a ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4,6 DICHLORO 3 (2 OXO 1 PHENYL 3 PYRROLIDINYLIDENEMETHYL) 1H INDOLE 2 CARBOXYLIC ACID; ACICLOVIR; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZYDAMINE; CAPSAICIN; DESIPRAMINE; DEXTROMETHORPHAN; DICLOFENAC; FLUPHENAZINE; GABAPENTIN; GANGLIOSIDE; IBUPROFEN; KETAMINE; LEVORPHANOL; LIDOCAINE; LORAZEPAM; MAPROTILINE; MEMANTINE; METHADONE; METHYLPREDNISOLONE; MORPHINE; NORTRIPTYLINE; OPIATE; OXYCODONE; PLACEBO; PREGABALIN; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VINCRISTINE; ANALGESIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NARCOTIC AGENT;

ACUPUNCTURE; ANALGESIA; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DEPRESSION; DIZZINESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESEARCH; DRUG WITHDRAWAL; ERYTHEMA MULTIFORME; HEART LEFT BUNDLE BRANCH BLOCK; HERPES ZOSTER; HUMAN; META ANALYSIS; NAUSEA; NEUROPATHIC PAIN; POSTHERPETIC NEURALGIA; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; XEROSTOMIA; CLINICAL TRIAL (TOPIC); METABOLISM; NEURALGIA; TIME;

ANALGESICS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLINICAL TRIALS AS TOPIC; HERPES ZOSTER; HUMANS; LIDOCAINE; METHYLPREDNISOLONE; NARCOTICS; NEURALGIA; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 33846583290     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020164     Document Type: Review

References (89)

1. Cunningham AL, Dworkin RH (2000) The management of post-herpetic neuralgia. Br Med J 321: 778-779.
2. Johnson RW (2001) Herpes zoster-predicting and minimizing the impact of post-herpetic neuralgia. J Antimicrob Chemother 47: 1-8.
3. Fields HL, Rowbotham MC, Baron R (1998) Postherpetic neuralgia: Irritable nociceptors and deafferentation. Neurobiol Dis 5: 209-227.
4. Bridges D, Thompson SWN, Rice ASC (2001) Mechanisms of neuropathic pain. Br J Anaesth 87: 12-26.
5. Woolf CJ, Mannion RJ (1999) Neuropathic pain: Aetiology, symptoms, mechanisms, and management. Lancet 353: 1959-1964.
6. Rowbotham MC, Petersen KL (2001) Zoster-associated pain and neural dysfunction. Pain 93: 1-5.
7. Alper BS, Lewis PR (2002) Treatment of postherpetic neuralgia, a systematic review of the literature. J Fam Pract 51: 121-128.
8. Collins S, Moore RA, McQuay HJ, Wiffen PJ (2000) Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J Pain Symptom Manage 20: 449-458.
9. Volmink J, Lancaster T, Gray S, Silagy C (1996) Treatments for postherpetic neuralgia - A systematic review of randomized controlled trials. Fam Pract 13: 84-91.
10. Sindrup SH, Jensen TS (1999) Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 83: 389-400.
11. Rice ASC, Maton S, Post Herpetic Neuralgia Study Group (2001) Gabapentin in postherpetic neuralgia; a randomised, double-blind, controlled study. Pain 94: 215-224.
12. Serpell MG, Neuropathic Pain Study Group (2002) Gabapentin in neuropathic pain syndromes: A randomised, double-blind, placebo-controlled trial. Pain 99: 557-566.
13. Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, et al. (2003) Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 60: 1274-1283.
14. Boureau F, Legallicier P, Kabir-Ahmadi M (2003) Tramadol in postherpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Pain 104: 323-331.
15. Rowbotham MC, Harden N, Stacey B, Bernstein P, Magnus-Miller L (1998) Gabapentin for treatment of postherpetic neuralgia. JAMA 280: 1837-1843.
16. Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka M, et al. (2000) Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 343: 1514-1519.
17. Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, et al. (1999) Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 24: 287-293.
18. Raja SN, Haythornwaite JA, Pappagallo M, Clark MR, Travison TG, et al. (2002) Opioids versus antidepressants in postherpetic neuralgia. Neurology 59: 1015-1021.
19. Sang CN, Booher S, Gilron I, Parada S, Max MB (2002) Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: Efficacy and dose-response trials. Anesthesiology 96: 1053-1061.
20. Sabatowski R, Galvez R, Cherry DA, Jacquot F, Vincent E, et al. (2004) Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial. Pain 109: 26-35.
21. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, et al. (2003) Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 348: 1223-1232.
22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, et al. (1996) Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17: 1-12.
23. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, et al. (1996) A systematic review of antidepressants in neuropathic pain. Pain 68: 217-227.
24. Moore RA, Tramer M, Carroll D, Wiffen PJ, McQuay HJ (1998) A quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. Br Med J 316: 333-338.
25. Altman DG (1998) Confidence intervals for the number needed to treat. Br Med J 317: 1309-1312.
26. Fleiss JL (1981) Other measures of association: The odds ratio. Statistical methods for rates and proportions, Chichester: John Wiley and Sons. p 64.
27. Armitage P, Berry G (1990) Statistical methods in medical research. Oxford: Blackwell Scientific Publications, pp 194-196.
28. Galbraith RF (1988) A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7: 889-894.
29. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, et al. (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Lancet 354: 1896-1900.
30. Watson CP, Vernich L, Chipman M, Reed K (1998) Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurology 51: 1166-1171.
31. Watson CP, Chipman M, Reed K, Evans RJ, Birkett N (1992) Amitriptyline versus maprotiline in postherpetic neuralgia: A randomized, double-blind, crossover trial. Pain 48: 29-36.
32. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, et al. (1982) Amitriptyline versus placebo in postherpetic neuralgia. Neurology 32: 671-673.
33. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, et al. (1988) Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 38: 1427-1432.
34. Kishore-Kumar R, Max MB, Schafer SC, Gaughan AM, Smoller B, et al. (1990) Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 47: 305-312.
35. Graff-Radford SB, Shaw LR, Naliboff BN (2000) Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 16: 188-192.
36. Watson CP, Babul N (1998) Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 50: 1837-1841.
37. Rowbotham MC, Reisner-Keller LA, Fields HL (1991) Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41: 1024-1028.
38. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB (1997) High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 48: 1212-1218.
39. Wallace MS, Rowbotham MC, Katz NP, Dworkin RH, Dotson RM, et al. (2002) A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology 59: 1694-1700.
40. Eisenberg E, Kleiser A, Dortort A, Haim T, Yarnitsky D (1998) The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: A double-blind, placebo-controlled study. Eur J Pain 2: 321-327.
41. Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE (1989) Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 21: 265-270.
42. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, et al. (1993) A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 15: 510-526.
43. De Benedittis G, Lorenzetti A (1996) Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: A double-blind crossover placebo-controlled study. Pain 65: 45-52.
44. McQuay HJ, Carroll D, Moxon A, Glynn CJ, Moore RA (1990) Benzydamine cream for the treatment of post-herpetic neuralgia: Minimum duration of treatment periods in a cross-over trial. Pain 40: 131-135.
45. Galer BS, Rowbotham MC, Perander J, Friedman E (1999) Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: Results of an enriched enrollment study. Pain 80: 533-538.
46. Rowbotham MC, Davies PS, Verkempinck C, Galer BS (1996) Lidocaine patch: Double-blind controlled study of a new method for post-herpetic neuralgia. Pain 65: 39-44.
47. Rowbotham MC, Davies PS, Fields HL (1995) Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 37: 246-253.
48. Baranowski AP, De Courcey J, Bonello E (1999) A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 17: 429-433.
49. Surman OS, Flynn T, Schooley RT, Baer L, Parker S, et al. (1990) A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia. Psychosomatics 31: 287-292.
50. Max MB, Schafer SC, Culnane M, Dubner R, Gracely RH (1988) Association of pain relief with drug side effects in postherpetic neuralgia: A single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin Pharmacol Ther 43: 363-371.
51. Kishore-Kumar R, Schafer SC, Lawlor BA, Murphy DL, Max MB (1989) Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Pain 37: 223-227.
52. Dowd NP, Day F, Timon D, Cunningham AJ, Brown L (1999) Iontophoretic vincristine in the treatment of postherpetic neuralgia: A double-blind, randomized, controlled trial. J Pain Symptom Manage 17: 175-180.
53. Lewith GT, Field J, Machin D (1983) Acupuncture compared with placebo in post-herpetic pain. Pain 17: 361-368.
54. Staughton RC, Good J (1990) Double-blind, placebo-controlled clinical trial of a mixture of gangliosides ('Cronassial') in post-herpetic neuralgia. Curr Med Res Opin 12: 169-176.
55. Committee for Medicinal Products for Human Use (2004) Guideline on clinical investigation of medicinal products intended for use in the treatment of neuropathic pain. London: European Medicines Agency. Report Number CHMP/EWP/252/03. Available: http://www.emea.eu.int/pdfs/human/ewp/025203en.pdf. Accessed 26 May 2005.
56. McQuay HJ, Moore RA (1998) An evidence-based resource for pain relief. Oxford: Oxford University Press. 264 p.
57. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94: 149-158.
58. The British Pain Society (2004) Recommendations for the appropriate use of opioids for persistent non-cancer pain. Available at: http://www. britishpainsociety.org/pdf/opioids_doc_2004.pdf. Accessed: 8 June 2005.
59. Griffin JW, McArthur JC, Polydefkis M (2001) Assessment of cutaneous innervation by skin biopsies. Curr Opin Neurol 14: 655-659.
60. Nelson DA (1988) Dangers from methylprednisolone acetate therapy by intraspinal injection. Arch Neurol 45: 804-806.
61. Nelson DA, Landau WM (2001) Intraspinal steroids: History, efficacy, accidentality and controversy with review of United States Food and Drug Administration reports. J Neurol Neurosurg Psychiatry 70: 433-443.
62. Nelson DA, Landau WM, Lampe JB, Hindinger C, Reichmann H, et al. (2001) Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 344: 1019-1022.
63. Haythornthwaite JA, Benrud-Larson LM (2000) Psychological aspects of neuropathic pain. Clin J Pain 16: S101-S105.
64. Tajti J, Szok D, Vecsi L (1999) Topical acetylsalicylic acid versus lidocaine for postherpetic neuralgia; results of a double blind comparative trial. Neurobiology 7: 103-108.
65. Bowsher D, Gill H (1991) Aspirin in chloroform lotion for topical pain relief in postherpetic neuralgia: A double blind trial. J Pain 9: 16-17.
66. Devers A, Galer BS (2000) Topical lidocaine patch relieves a variety of neuropathic pain conditions; an open label study. Clin J Pain 16: 205-208.
67. Coniam SW, Hunton J (1988) Benzydamine cream in post-herpetic neuralgia. Anaesthesia 43: 901.
68. Meier T, Wasner G, Faust M, Kuntzer T, Ochsner F, et al. (2003) Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: A randomized, double-blind, placebo-controlled study. Pain 106: 151-158.
69. Acosta EP, Balfour HH Jr (2001) Acyclovir for treatment of postherpetic neuralgia: Efficacy and pharmacokinetics. Antimicrob Agents Chemother 45: 2771-2774.
70. Killian JM, Fromm GH (1968) Carbamazepine in the treatment of neuralgia. Use of side effects. Arch Neurol 19: 129-136.
71. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H (1994) Relief of postherpetic neuralgia with the receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 58: 347-354.
72. Brill S, Sedgwick PM, Hamann W, di Vadi PP (2002) Efficacy of intravenous magnesium in neuropathic pain. Br J Anaesth 89: 711-714.
73. Stow PJ, Glynn CJ, Minor B (1989) EMLA cream in the treatment of postherpetic neuralgia. Efficacy and pharmacokinetic profile. Pain 39: 301-305.
74. King RB (1993) Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia. Arch Neurol 50: 1046-1053.
75. Abadair AR, Kraynack BJ, Mayda J, Gintautas J (1996) Postherpetic neuralgia: Response to topical clonidine. Proc West Pharmacol Soc 39: 47-48.
76. Watson CPN, Evans RJ (1985) A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain 23: 387-394.
77. Watson CP, Evans RJ, Watt VR (1988) Post-herpetic neuralgia and topical capsaicin. Pain 33: 333-340.
78. Nathan PW (1978) Chlorprothixene (taractan) in post-herpetic neuralgia and other severe chronic pains. Pain 5: 367-371.
79. Langohr HD, Stohr M, Petruch F (1982) An open and double-blind crossover study on the efficacy of clomipramine (Anafranil) in patients with painful mono- and polyneuropathies. Eur Neurol 21: 309-317.
80. Ikebe H, Miyagawa A, Mizutani A, Miyamoto M, Taniguchi K, et al. (1995) The effect of iontophoresis with several calcium channel blockers for PHN patients. Masui 44: 428-433.
81. Gobel H, Stadler T (1997) Treatment of post-herpes zoster pain with tramadol. Results of an open pilot study versus clomipramine with or without levomepromazine. Drugs 53: 34-39.
82. Watt JW, Wiles JR, Bowsher DR (1996) Epidural morphine for postherpetic neuralgia. Anaesthesia 51: 647-651.
83. Gerson GR, Jones RB, Luscombe DK (1977) Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia. Postgrad Med J 53: 104-109.
84. De Benedittis G, Besana F, Lorenzetti A (1992) A new topical treatment for acute herpetic neuralgia and post-herpetic neuralgia: The aspirin/diethyl ether mixture. An open-label study plus a double-blind controlled clinical trial. Pain 48: 383-390.
85. Layman PR, Argyras E, Glynn CJ (1986) Iontophoresis of vincristine versus saline in post-herpetic neuralgia. A controlled trial. Pain 25: 165-170.
86. Catala E, Ferrandiz M, Aliaga L, Serra R, Castra MA, et al. (1994) Intravenous lidocaine compared with sympathetic blocks as treatment for postherpetic neuralgia. A 1 year survey. The Pain Clinic 7: 205-210.
87. Tamakawa S, Tsujimoto J, Iharada A, Ogawa H (1999) Treatment of postherpetic neuralgia by topical application of prostaglandin E1-vaseline mixture - A single blind controlled clinical trial. Masui 48: 292-294.
88. Moriyama M, Kitamura A, Ikezaki H, Nakanishi K, Kim C, et al. (2004) Systemic ATP infusion improves spontaneous pain and tactile allodynia, but not tactile hypesthesia, in patients with postherpetic neuralgia. J Anesth 18: 177-180.
89. Rutgers MJ, Van Romunde LKJ, Osman PO (1988) A small randomised comparative trial of acupuncture versus transcutaneous electrical neurostimulation in postherpetic neuralgia. The Pain Clinic 2: 87-89.